India to United States: Valsartan Export Trade Route

The India to United States Valsartan corridor is one of India's established pharmaceutical export routes, with 776 shipments documented worth a combined $101.4M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 52% of all export value, reflecting the consolidated nature of India's valsartan manufacturing sector.

Across 15 active suppliers, the average shipment value stands at $130.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with valsartan's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 23.6%, placing it at rank #18 among India's top valsartan export destinations globally.

On the import side, key buyers of Indian valsartan in United States include MYLAN PHARMACEUTICALS INC,, MACLEODS PHARMA USA ,INC, MACLEODS PHARMA USA,INC and 44 others. MYLAN PHARMACEUTICALS INC, is the single largest importer with 62 shipments valued at $34.0M USD.

India's valsartan exports to United States are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 144 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 15 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MYLAN LABORATORIES LIMITED, MACLEODS PHARMACEUTICALS LTD, ALEMBIC PHARMACEUTICALS LIMITED — together account for 87% of total trade value on this route. The average shipment value of $130.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as valsartan tablets usp 80 mg 90bt tab 51660 packs and drugs and pharmaceuticals harmless medicines valsartan and hydrochlorothiazide tablets usp (320 mg/ 25 mg), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MYLAN PHARMACEUTICALS INC, is the largest importer with 62 shipments worth $34.0M USD — representing 34% of all valsartan imports from India on this route. A total of 47 buyers are active on this corridor.